Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 27% ± 13% | |
astrocyte | 11 studies | 31% ± 15% | |
oligodendrocyte precursor cell | 9 studies | 29% ± 13% | |
glutamatergic neuron | 8 studies | 44% ± 28% | |
oligodendrocyte | 8 studies | 29% ± 9% | |
GABAergic neuron | 7 studies | 48% ± 24% | |
macrophage | 7 studies | 30% ± 10% | |
microglial cell | 7 studies | 27% ± 7% | |
epithelial cell | 7 studies | 33% ± 18% | |
fibroblast | 7 studies | 29% ± 10% | |
smooth muscle cell | 7 studies | 23% ± 4% | |
interneuron | 6 studies | 42% ± 26% | |
adipocyte | 6 studies | 28% ± 6% | |
endothelial cell of lymphatic vessel | 6 studies | 27% ± 9% | |
mast cell | 5 studies | 21% ± 5% | |
dendritic cell | 5 studies | 17% ± 2% | |
cardiac muscle cell | 4 studies | 38% ± 7% | |
lymphocyte | 4 studies | 29% ± 9% | |
pericyte | 4 studies | 29% ± 12% | |
renal principal cell | 4 studies | 39% ± 15% | |
neuron | 3 studies | 28% ± 15% | |
GABAergic interneuron | 3 studies | 27% ± 3% | |
myeloid cell | 3 studies | 22% ± 1% | |
abnormal cell | 3 studies | 40% ± 17% | |
CD4-positive, alpha-beta T cell | 3 studies | 18% ± 0% | |
T cell | 3 studies | 19% ± 2% | |
type I pneumocyte | 3 studies | 23% ± 7% | |
transit amplifying cell | 3 studies | 38% ± 29% | |
renal alpha-intercalated cell | 3 studies | 39% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 8483.60 | 653 / 653 | 100% | 21.64 | 603 / 605 |
esophagus | 100% | 4860.05 | 1440 / 1445 | 100% | 15.18 | 183 / 183 |
breast | 100% | 5350.46 | 459 / 459 | 100% | 20.95 | 1114 / 1118 |
kidney | 100% | 6014.42 | 89 / 89 | 99% | 22.98 | 895 / 901 |
lung | 100% | 4492.80 | 578 / 578 | 99% | 14.20 | 1144 / 1155 |
bladder | 100% | 5977.38 | 21 / 21 | 98% | 10.64 | 496 / 504 |
prostate | 100% | 4781.16 | 245 / 245 | 98% | 11.36 | 494 / 502 |
pancreas | 100% | 4289.97 | 328 / 328 | 98% | 13.87 | 175 / 178 |
ovary | 100% | 7279.06 | 180 / 180 | 98% | 11.33 | 422 / 430 |
uterus | 100% | 6708.45 | 170 / 170 | 98% | 12.15 | 450 / 459 |
intestine | 100% | 5220.55 | 965 / 966 | 98% | 10.98 | 515 / 527 |
skin | 100% | 5594.70 | 1809 / 1809 | 97% | 22.21 | 459 / 472 |
adrenal gland | 100% | 3747.33 | 258 / 258 | 97% | 12.62 | 223 / 230 |
stomach | 100% | 4300.27 | 359 / 359 | 97% | 11.90 | 277 / 286 |
brain | 97% | 2800.51 | 2556 / 2642 | 100% | 13.44 | 702 / 705 |
liver | 97% | 1728.92 | 220 / 226 | 89% | 9.54 | 361 / 406 |
adipose | 100% | 5429.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6248.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5087.79 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4557.61 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.72 | 1 / 1 |
heart | 97% | 4396.76 | 836 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.73 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 10.89 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 84% | 8.77 | 67 / 80 |
peripheral blood | 29% | 1638.35 | 268 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048678 | Biological process | response to axon injury |
GO_0031103 | Biological process | axon regeneration |
GO_0046653 | Biological process | tetrahydrofolate metabolic process |
GO_0009086 | Biological process | methionine biosynthetic process |
GO_0009235 | Biological process | cobalamin metabolic process |
GO_0032259 | Biological process | methylation |
GO_0007399 | Biological process | nervous system development |
GO_0050667 | Biological process | homocysteine metabolic process |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_0005829 | Cellular component | cytosol |
GO_0031419 | Molecular function | cobalamin binding |
GO_0008705 | Molecular function | methionine synthase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MTR |
Protein name | 5-methyltetrahydrofolate-homocysteine methyltransferase Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase) |
Synonyms | |
Description | FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol . MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate . The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine . . FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol. MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate. The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine. . FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol. MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate. The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine. . FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol. MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate. The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine. . FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol. MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate. The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine. . FUNCTION: Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol. MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate. The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine. . |
Accessions | ENST00000681177.1 ENST00000650888.1 ENST00000366577.10 [Q99707-1] A0A7P0TAV2 ENST00000652435.1 A0A7P0T9G7 ENST00000535889.6 [Q99707-2] ENST00000651455.1 A0A494C1A2 ENST00000366576.3 A0A494C064 A0A7P0T956 ENST00000681102.1 A0A6Q8PGK3 A0A7P0TA06 ENST00000674797.2 ENST00000463959.1 B7ZLW8 Q99707 A0A7P0TAJ0 ENST00000679842.1 B1ANE3 |